Need to mass-produce tablets with quality solid dosage in a quick and cost-effective way? The time that a formulation is under compression is one area you should address through the use of innovative tablet tooling. Alex Bunting, I Holland Compaction plays an important role in the quality of the final tablet. In order to produce…
Kodak internal review finds problems but no lawbreaking over pharma loan deal
Shares of Eastman Kodak (NYSE: KODK) are up two-thirds so far this week after a special committee set up by the company’s board found no lawbreaking in controversial stock trades made by top management in the leadup to announcing a $765 million federal government loan to support a shift to pharmaceutical manufacturing. CEO Jim Continenza…
Feds unveil COVID-19 vaccine distribution plan
The Trump administration today released a plan to distribute an eventual COVID-19 vaccine free of charge, initially to targeted groups and more broadly as supply increases. The government is planning a phased distribution using a contract awarded to McKesson in August. The first recipients could include: Healthcare personnel likely to be exposed to or treat people…
Thermo Fisher to manufacture Inovio COVID-19 vaccine candidate
Inovio Pharmaceuticals (NSDQ:INO) announced that Thermo Fisher Scientific (NYSE:TMO) will manufacture its COVID-19 vaccine candidate. Plymouth Meeting, Pa.-based Inovio said in a news release yesterday that Thermo Fisher signed a letter of intent to manufacture the INO-4800 COVID-19 vaccine candidate, joining a consortium of third-party manufacturers that aim to produce 100 million doses of Inovio’s vaccine by 2021,…
Schott producing vials for 3 of 4 COVID-19 vaccine candidates
Specialty glass manufacturer Schott announced today that it is delivering vials to three out of every four COVID-19 vaccine projects undergoing phase I, II, and III testing , according to Global Data. The Mainz, Germany-based company has delivered millions of glass vials to SARS-CoV-2 programs, including partners of the Trump administration’s Operation Warp Speed vaccine…
Teknova ups production of viral transport media to support COVID-19 testing
Teknova (Hollister, Calif.) recently announced that it has significantly scaled up production of its viral transport medium and saline to support COVID-19 testing. VTM (or universal sample transport medium) is a sample collection solution for virus stabilization that maintains virus viability from the point of collection to the testing laboratory. It’s but one of a…
Could Vaxxas’ tiny patches enable a better COVID-19 vaccine?
Tiny vaccine delivery patches could solve logistical challenges, but they face manufacturing hurdles. Here’s how Vaxxas is trying to overcome them. Merck (NYSE:MRK) and Vaxxas announced earlier this year that the pharmaceutical giant was using Vaxxas’ High Density Microarray Patch (HD-MAP) platform as a delivery platform for a vaccine candidate. Vaxxas did not disclose what…
Nestlé to acquire peanut allergy drugmaker for $2.6B
Nestlé (VTX:NESN) announced today that it entered into a definitive agreement to acquire food allergy treatment developer Aimmune Therapeutics (NSDQ:AIMT). Under the agreement, Nestlé Health Science (NHSc) would acquire Aimmune with a cash offer for $34.50 per share, totaling approximately $2.6 billion. The per-share price for Aimmune represents a 174% premium to the company’s closing share…
JanOne selects partner to bottle its PAD drug
JanOne recently announced that it has forged a partnership with a company to bottle and label its JAN101 drug. JanOne said it is preparing its investigational new drug application for FDA submission as a potential treatment for vascular complications caused by COVID-19. The drug is already planned for use in Phase 2b trials as a…
Report: Top FDA official vows to quit if vaccine approved prematurely
A top FDA official has threatened to resign if the Trump administration moves too quickly to approve a vaccine for COVID-19, according to a published report. Peter Marks, director of the agency’s Center for Biologics Evaluation and Research (CBER), made the threat over concerns a vaccine would be approved without being proven safe and effective,…